Loading company…
New York-based Redpin Therapeutics develops gene therapies for chronic diseases.
Founded in 2017 in New York, US, Redpin Therapeutics focuses on gene therapy development for chronic diseases. The company was acquired on November 16, 2022 by a consortium that included Patient Square Capital, and its platform and pipeline are to be integrated into Kriya's gene therapy engine. Elma Hawkins is CEO. Its latest funding was a USD 15.50 mn Series A round, and the company plans to expand its offerings in North America and Europe.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in